Acute Myeloid Leukemia Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Acute Myeloid Leukemia Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Myeloid Leukemia Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Myeloid Leukemia Therapeutics Overall Market Size
2.1 Global Acute Myeloid Leukemia Therapeutics Market Size: 2022 VS 2029
2.2 Global Acute Myeloid Leukemia Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Myeloid Leukemia Therapeutics Players in Global Market
3.2 Top Global Acute Myeloid Leukemia Therapeutics Companies Ranked by Revenue
3.3 Global Acute Myeloid Leukemia Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Acute Myeloid Leukemia Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Acute Myeloid Leukemia Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Myeloid Leukemia Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Acute Myeloid Leukemia Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Myeloid Leukemia Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Acute Myeloid Leukemia Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Pipeline Drugs
4.1.3 Chemotherapy Drugs
4.1.4 Chemotherapy Regimens
4.2 By Type - Global Acute Myeloid Leukemia Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Acute Myeloid Leukemia Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Acute Myeloid Leukemia Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Acute Myeloid Leukemia Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acute Myeloid Leukemia Therapeutics Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Home Care
5.2 By Application - Global Acute Myeloid Leukemia Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Acute Myeloid Leukemia Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Acute Myeloid Leukemia Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Acute Myeloid Leukemia Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Acute Myeloid Leukemia Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Acute Myeloid Leukemia Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Acute Myeloid Leukemia Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Acute Myeloid Leukemia Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Acute Myeloid Leukemia Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Acute Myeloid Leukemia Therapeutics Revenue, 2018-2029
6.3.2 US Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.3.3 Canada Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.3.4 Mexico Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Acute Myeloid Leukemia Therapeutics Revenue, 2018-2029
6.4.2 Germany Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.4.3 France Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.4.4 U.K. Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.4.5 Italy Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.4.6 Russia Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.4.8 Benelux Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Acute Myeloid Leukemia Therapeutics Revenue, 2018-2029
6.5.2 China Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.5.3 Japan Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.5.4 South Korea Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.5.6 India Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Acute Myeloid Leukemia Therapeutics Revenue, 2018-2029
6.6.2 Brazil Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.6.3 Argentina Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acute Myeloid Leukemia Therapeutics Revenue, 2018-2029
6.7.2 Turkey Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.7.3 Israel Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
6.7.5 UAE Acute Myeloid Leukemia Therapeutics Market Size, 2018-2029
7 Acute Myeloid Leukemia Therapeutics Companies Profiles
7.1 Ambit Biosciences Corporation
7.1.1 Ambit Biosciences Corporation Company Summary
7.1.2 Ambit Biosciences Corporation Business Overview
7.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Major Product Offerings
7.1.4 Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Ambit Biosciences Corporation Key News & Latest Developments
7.2 Genzyme Corporation Celgene Corporation
7.2.1 Genzyme Corporation Celgene Corporation Company Summary
7.2.2 Genzyme Corporation Celgene Corporation Business Overview
7.2.3 Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Major Product Offerings
7.2.4 Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Genzyme Corporation Celgene Corporation Key News & Latest Developments
7.3 Clavis Pharma ASA
7.3.1 Clavis Pharma ASA Company Summary
7.3.2 Clavis Pharma ASA Business Overview
7.3.3 Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Major Product Offerings
7.3.4 Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Clavis Pharma ASA Key News & Latest Developments
7.4 Sunesis Pharmaceuticals
7.4.1 Sunesis Pharmaceuticals Company Summary
7.4.2 Sunesis Pharmaceuticals Business Overview
7.4.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Major Product Offerings
7.4.4 Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Sunesis Pharmaceuticals Key News & Latest Developments
7.5 Cephalon
7.5.1 Cephalon Company Summary
7.5.2 Cephalon Business Overview
7.5.3 Cephalon Acute Myeloid Leukemia Therapeutics Major Product Offerings
7.5.4 Cephalon Acute Myeloid Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Cephalon Key News & Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Major Product Offerings
7.6.4 Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Bristol-Myers Squibb Key News & Latest Developments
7.7 Novartis International AG
7.7.1 Novartis International AG Company Summary
7.7.2 Novartis International AG Business Overview
7.7.3 Novartis International AG Acute Myeloid Leukemia Therapeutics Major Product Offerings
7.7.4 Novartis International AG Acute Myeloid Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Novartis International AG Key News & Latest Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Company Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Acute Myeloid Leukemia Therapeutics Major Product Offerings
7.8.4 GlaxoSmithKline Acute Myeloid Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.8.5 GlaxoSmithKline Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Acute Myeloid Leukemia Therapeutics Market Opportunities & Trends in Global Market
Table 2. Acute Myeloid Leukemia Therapeutics Market Drivers in Global Market
Table 3. Acute Myeloid Leukemia Therapeutics Market Restraints in Global Market
Table 4. Key Players of Acute Myeloid Leukemia Therapeutics in Global Market
Table 5. Top Acute Myeloid Leukemia Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Acute Myeloid Leukemia Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Acute Myeloid Leukemia Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Acute Myeloid Leukemia Therapeutics Product Type
Table 9. List of Global Tier 1 Acute Myeloid Leukemia Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Myeloid Leukemia Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Acute Myeloid Leukemia Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Acute Myeloid Leukemia Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Acute Myeloid Leukemia Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Acute Myeloid Leukemia Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Acute Myeloid Leukemia Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Acute Myeloid Leukemia Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Ambit Biosciences Corporation Company Summary
Table 31. Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Product Offerings
Table 32. Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Ambit Biosciences Corporation Key News & Latest Developments
Table 34. Genzyme Corporation Celgene Corporation Company Summary
Table 35. Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Product Offerings
Table 36. Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Genzyme Corporation Celgene Corporation Key News & Latest Developments
Table 38. Clavis Pharma ASA Company Summary
Table 39. Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Product Offerings
Table 40. Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Clavis Pharma ASA Key News & Latest Developments
Table 42. Sunesis Pharmaceuticals Company Summary
Table 43. Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Product Offerings
Table 44. Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Sunesis Pharmaceuticals Key News & Latest Developments
Table 46. Cephalon Company Summary
Table 47. Cephalon Acute Myeloid Leukemia Therapeutics Product Offerings
Table 48. Cephalon Acute Myeloid Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Cephalon Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Summary
Table 51. Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Product Offerings
Table 52. Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Bristol-Myers Squibb Key News & Latest Developments
Table 54. Novartis International AG Company Summary
Table 55. Novartis International AG Acute Myeloid Leukemia Therapeutics Product Offerings
Table 56. Novartis International AG Acute Myeloid Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis International AG Key News & Latest Developments
Table 58. GlaxoSmithKline Company Summary
Table 59. GlaxoSmithKline Acute Myeloid Leukemia Therapeutics Product Offerings
Table 60. GlaxoSmithKline Acute Myeloid Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. GlaxoSmithKline Key News & Latest Developments
List of Figures
Figure 1. Acute Myeloid Leukemia Therapeutics Segment by Type in 2022
Figure 2. Acute Myeloid Leukemia Therapeutics Segment by Application in 2022
Figure 3. Global Acute Myeloid Leukemia Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Acute Myeloid Leukemia Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Acute Myeloid Leukemia Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute Myeloid Leukemia Therapeutics Revenue in 2022
Figure 8. By Type - Global Acute Myeloid Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Acute Myeloid Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Acute Myeloid Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Acute Myeloid Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Acute Myeloid Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Acute Myeloid Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Acute Myeloid Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Acute Myeloid Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Acute Myeloid Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Acute Myeloid Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Cephalon Acute Myeloid Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis International AG Acute Myeloid Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. GlaxoSmithKline Acute Myeloid Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
